Natriuretic peptides in the pathophysiology of congestive heart failure
- 1 May 2000
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 2 (3), 198-205
- https://doi.org/10.1007/s11886-000-0069-3
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996
- Angiotensin II in the Evolution of Experimental Heart FailureHypertension, 1996
- Association of Restriction Fragment Length Polymorphism at the Atrial Natriuretic Peptide Gene Locus with Aldosterone Responsiveness to Angiotensin in Aldosterone-Producing AdenomaBiochemical and Biophysical Research Communications, 1994
- Inhibition of cyclic GMP phosphodiesterases augments renal responses to atrial natriuretic factor in congestive heart failureJournal of Cardiac Failure, 1994
- Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionThe Lancet, 1993
- C-Type Natriuretic Peptide Inhibits Intimal Thickening after Vascular InjuryBiochemical and Biophysical Research Communications, 1993
- A dicarba analog of β‐atrial natriuretic peptide (β‐ANP) inhibits guanosine 3′,5′‐cyclic monophosphate production induced by α‐ANP in cultured rat vascular smooth muscle cellsFEBS Letters, 1989
- Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segmentsLife Sciences, 1988
- Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure.Circulation, 1985
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981